Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy.
Tomasz BednarczukLutz SchomburgPublished in: Hormones (Athens, Greece) (2019)
Additional randomized clinical trials with clinically relevant endpoints are urgently needed to further aid in clinical decision-making, including better stratification of Graves' disease patients, who are most likely to benefit from Se supplementation.